VALN vs FTH
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
VALN · Valneva$5.51 ▼ 2.31%
FTH · Faeth Therapeutics$22.05 ▲ 10.69%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- VALN -38.0%
- FTH +129.4%
Head to head
| Metric | VALN | FTH |
|---|---|---|
| Price | $5.51 | $22.05 |
| Change today | ▼ 2.31% | ▲ 10.69% |
| Market cap | $524.15M | $569.86M |
| Return, 3 months | +4.0% | -22.8% |
| Return, year to date | -37.5% | +106.7% |
| Return, 1 year | -36.8% | +142.3% |
| P/E (TTM) | – | – |
| P/B | 5.8 | 3.5 |
| P/E percentile vs own 5y | 91st | 96th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | -27.7% | – |
| Net profit growth (YoY) | -169.3% | -224.3% |
| Gross margin | 16.4% | – |
| Operating margin | -80.4% | – |
| Net margin | -110.3% | – |
| Return on equity | -117.8% | -195.3% |
| Analyst target vs. price | +148.1% | +161.2% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 45 | 50 |
| 30-day volatility | 51.4% | 96.9% |
| Max drawdown, 1 year | -60.1% | -69.2% |
| Trend read | Strong downtrend | Leaning bullish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- FTH is the largest of the group by market value.
- FTH has returned the most over the past year.
- VALN has been the calmest stock over the last 30 days.